Question 1

What is Martine Rothblatt?

Accepted Answer

Martine Rothblatt is a Person.

Question 2

How often does Martine Rothblatt appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Martine Rothblatt first tracked by Ergen?

Accepted Answer

First tracked on Apr 08, 2026.

Question 4

When was Martine Rothblatt last mentioned in news?

Accepted Answer

Last active on Jul 02, 2026.

Question 5

What is Martine Rothblatt's current news sentiment?

Accepted Answer

Aggregate sentiment score: 20 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Martine Rothblatt in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Martine Rothblatt?

Accepted Answer

United Therapeutics CEO Sells Shares (Apr 08, 2026, 6 articles).

Question 8

How did the "United Therapeutics CEO Sells Shares" event impact Martine Rothblatt?

Accepted Answer

Martine Rothblatt, CEO of United Therapeutics, sold a substantial number of her shares in multiple transactions, decreasing her ownership by 19%. This insider selling activity is a key focus of the event.

Question 9

How did the "United Therapeutics acquires Thymmune Therapeutics" event impact Martine Rothblatt?

Accepted Answer

Martine Rothblatt, Chairperson and CEO of United Therapeutics, views the acquisition of Thymmune Therapeutics, Inc. as complementary to United Therapeutics' mission, highlighting the potential of Thymmune's platform to contribute to human healthcare and resolve root causes of diseases.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.